US FDA cuts animal testing for new cancer drugs
The United States Food and Drug Administration (FDA) is taking a significant step toward modernizing medical research by reducing the pharmaceutical industry’s reliance on animal testing. A new draft guidance specifically for monoclonal antibody cancer drugs suggests that developers can now bypass animal toxicity studies if sufficient human-based data exists. This marks a pivotal shift […]
US FDA cuts animal testing for new cancer drugs Read More »









